BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31815781)

  • 1. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy.
    Elgarten CW; Aplenc R
    Curr Opin Pediatr; 2020 Feb; 32(1):57-66. PubMed ID: 31815781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia.
    Medinger M; Lengerke C; Passweg J
    Cancer Genomics Proteomics; 2016 09-10; 13(5):317-29. PubMed ID: 27566651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia in children: Current status and future directions.
    Taga T; Tomizawa D; Takahashi H; Adachi S
    Pediatr Int; 2016 Feb; 58(2):71-80. PubMed ID: 26645706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in targeted therapies in acute myeloid leukemia.
    Bhansali RS; Pratz KW; Lai C
    J Hematol Oncol; 2023 Mar; 16(1):29. PubMed ID: 36966300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.
    DiNardo C; Lachowiez C
    Curr Hematol Malig Rep; 2019 Oct; 14(5):386-394. PubMed ID: 31350639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
    Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia: 2013 update on risk-stratification and management.
    Estey EH
    Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric acute myeloid leukemia: Insight into genetic landscape and novel targeted approaches.
    Tosic N; Marjanovic I; Lazic J
    Biochem Pharmacol; 2023 Sep; 215():115705. PubMed ID: 37532055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in treatment of de-novo pediatric acute myeloid leukemia.
    Ribeiro RC
    Curr Opin Oncol; 2014 Nov; 26(6):656-62. PubMed ID: 25226383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia.
    Tomizawa D; Tsujimoto SI
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring minimal residual disease in pediatric acute myeloid leukemia].
    Taga T
    Rinsho Ketsueki; 2020; 61(8):971-978. PubMed ID: 32908063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Management of Childhood Acute Myeloid Leukemia.
    Rubnitz JE
    Paediatr Drugs; 2017 Feb; 19(1):1-10. PubMed ID: 27785777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.
    Faulk K; Gore L; Cooper T
    Paediatr Drugs; 2014 Jun; 16(3):213-27. PubMed ID: 24639021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus.
    Montesinos P; Bergua J; Infante J; Esteve J; Guimaraes JE; Sierra J; Sanz MÁ
    Ann Hematol; 2019 Nov; 98(11):2467-2483. PubMed ID: 31667544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia.
    Oran B; Jorgensen JL; Marin D; Wang S; Ahmed S; Alousi AM; Andersson BS; Bashir Q; Bassett R; Lyons G; Chen J; Rezvani K; Popat U; Kebriaei P; Patel K; Rondon G; Shpall EJ; Champlin RE
    Haematologica; 2017 Jan; 102(1):110-117. PubMed ID: 27540139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukemia.
    Rubnitz JE; Gibson B; Smith FO
    Pediatr Clin North Am; 2008 Feb; 55(1):21-51, ix. PubMed ID: 18242314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical challenges in de novo pediatric acute myeloid leukemia.
    Klein K; de Haas V; Kaspers GJL
    Expert Rev Anticancer Ther; 2018 Mar; 18(3):277-293. PubMed ID: 29338495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia.
    Rubnitz JE; Gibson B; Smith FO
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):35-63. PubMed ID: 20113895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.